Åsmund Reikvam

1.6k total citations
61 papers, 467 citations indexed

About

Åsmund Reikvam is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Åsmund Reikvam has authored 61 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 10 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Åsmund Reikvam's work include Blood Pressure and Hypertension Studies (6 papers), Toxoplasma gondii Research Studies (6 papers) and Acute Myocardial Infarction Research (6 papers). Åsmund Reikvam is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Toxoplasma gondii Research Studies (6 papers) and Acute Myocardial Infarction Research (6 papers). Åsmund Reikvam collaborates with scholars based in Norway, Poland and Canada. Åsmund Reikvam's co-authors include Hege Salvesen Blix, Terje P. Hagen, Kirsten K. Viktil, Haakon B. Benestad, Tron Anders Moger, Morten Grundtvig, Jon Birger Haug, Knud Landmark, Randi Selmer and Ivar Aursnes and has published in prestigious journals such as Nature, European Heart Journal and Journal of Clinical Epidemiology.

In The Last Decade

Åsmund Reikvam

56 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Åsmund Reikvam Norway	13	153	110	63	58	50	61	467
J. Bouget France	15	77 0.5×	134 1.2×	42 0.7×	129 2.2×	33 0.7×	47	578
Marina Petrović Serbia	12	69 0.5×	95 0.9×	55 0.9×	144 2.5×	41 0.8×	65	585
Hyun Soon Sohn South Korea	14	70 0.5×	174 1.6×	79 1.3×	91 1.6×	26 0.5×	59	508
Susan M. Garabedian‐Ruffalo United States	10	130 0.8×	93 0.8×	31 0.5×	67 1.2×	14 0.3×	14	478
Abdulrazaq S. Al‐Jazairi Saudi Arabia	13	76 0.5×	128 1.2×	49 0.8×	28 0.5×	40 0.8×	36	441
Evelyn R. Hermes‐DeSantis United States	13	96 0.6×	127 1.2×	46 0.7×	182 3.1×	40 0.8×	43	760
Patricia R. Wigle United States	13	82 0.5×	39 0.4×	28 0.4×	50 0.9×	83 1.7×	39	422
R. Bruppacher Switzerland	16	94 0.6×	145 1.3×	29 0.5×	67 1.2×	290 5.8×	60	970
Laura McCullagh Ireland	14	68 0.4×	94 0.9×	121 1.9×	73 1.3×	27 0.5×	50	528
Stefan Vegter Netherlands	21	188 1.2×	156 1.4×	228 3.6×	177 3.1×	82 1.6×	40	1.3k

Countries citing papers authored by Åsmund Reikvam

Since Specialization

Citations

This map shows the geographic impact of Åsmund Reikvam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsmund Reikvam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsmund Reikvam more than expected).

Fields of papers citing papers by Åsmund Reikvam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åsmund Reikvam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsmund Reikvam. The network helps show where Åsmund Reikvam may publish in the future.

Co-authorship network of co-authors of Åsmund Reikvam

This figure shows the co-authorship network connecting the top 25 collaborators of Åsmund Reikvam. A scholar is included among the top collaborators of Åsmund Reikvam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsmund Reikvam. Åsmund Reikvam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haug, Jon Birger, Dag Berild, Mette Walberg, & Åsmund Reikvam. (2014). Hospital- and patient-related factors associated with differences in hospital antibiotic use: analysis of national surveillance results. Antimicrobial Resistance and Infection Control. 3(1). 40–40. 12 indexed citations

Wisløff, Torbjørn, Tove Ringerike, Gunhild Hagen, Åsmund Reikvam, & Marianne Klemp. (2013). Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation. 4 indexed citations

Haug, Jon Birger & Åsmund Reikvam. (2013). WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. Journal of Antimicrobial Chemotherapy. 68(12). 2940–2947. 13 indexed citations

Bogsrud, Martin P., Åsmund Reikvam, & Kjetil Retterstøl. (2013). Behandling med statiner. Tidsskrift for Den norske legeforening. 133(12/13). 1316–1319. 1 indexed citations

Blix, Hege Salvesen, Knud Landmark, Randi Selmer, & Åsmund Reikvam. (2012). Forskrivning av antihypertensive legemidler 1975-2010. Tidsskrift for Den norske legeforening. 132(10). 1224–1228. 9 indexed citations

Selmer, Randi, Hege Salvesen Blix, Knud Landmark, & Åsmund Reikvam. (2012). Choice of initial antihypertensive drugs and persistence of drug use—a 4-year follow-up of 78,453 incident users. European Journal of Clinical Pharmacology. 68(10). 1435–1442. 12 indexed citations

Haug, Jon Birger, et al.. (2011). Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals. BMC Medical Research Methodology. 11(1). 166–166. 8 indexed citations

Viktil, Kirsten K., Hege Salvesen Blix, & Åsmund Reikvam. (2009). The Janus face of polypharmacy – overuse versus underuse of medication. Norsk Epidemiologi. 18(2). 14 indexed citations

Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). Klinisk bruk av COX-hemmere – en konsensus. Tidsskrift for Den Norske Laegeforening. 2 indexed citations

10.

Reikvam, Åsmund, Sofie Hexeberg, Tore K Kvien, et al.. (2006). [Clinical use of COX inhibitors--a consensus].. PubMed. 126(5). 591–5. 5 indexed citations

11.

Landmark, Knud & Åsmund Reikvam. (2005). ACE-hemmer eller AII-reseptorblokker ved hjertesvikt og hjerteinfarkt?. Tidsskrift for Den Norske Laegeforening.

12.

Reikvam, Åsmund, et al.. (2003). Warfarinbehandling og blødninger. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

13.

Fretheim, Atle, Arild Bjørndal, Andrew D Oxman, et al.. (2002). Hvilke kolesterolsenkende legemidler bør brukes for primærforebygging av hjerte- og karsykdommer?. Tidsskrift for Den Norske Laegeforening. 2 indexed citations

14.

Fretheim, Atle, Arild Bjørndal, Andrew D Oxman, et al.. (2002). Retningslinjer for medikamentell primærforebygging av hjerte- og karsykdommer - hvem bør behandles?. Tidsskrift for Den Norske Laegeforening. 3 indexed citations

15.

Reikvam, Åsmund & Terje P. Hagen. (2002). Markedly Changed Age Distribution among Patients Hospitalized for Acute Myocardial Infarction. Scandinavian Cardiovascular Journal. 36(4). 221–224. 8 indexed citations

16.

Reikvam, Åsmund & Diane Ketley. (1997). Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals,. International Journal of Cardiology. 61(1). 79–83. 5 indexed citations

17.

Reikvam, Åsmund. (1996). [Use of thrombolytic agents and other drugs in acute myocardial infarction].. PubMed. 116(14). 1671–4. 2 indexed citations

18.

Benestad, Haakon B., et al.. (1977). Hydroxyurea (HU) in experimental hematology. I. Characterization of in vitro and in vivo effects on progenitor and transit cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(5). 408–14. 12 indexed citations

19.

Reikvam, Åsmund. (1976). Macrophage proliferation and activation during Toxoplasma gondii infection in mice: relationship to lymphocyte stimulation. Apmis. 124–130. 1 indexed citations

20.

Reikvam, Åsmund & E. Arne Høiby. (1975). PHAGOCYTOSIS AND MICROBICIDAL CAPACITY OF MOUSE MACROPHAGES NON‐SPECIFICALLY ACTIVATED IN VITRO. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 83C(2). 121–128. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact